1 – 10 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Immunomodulation—A Molecular Solution to Treating Patients with Severe Bladder Pain Syndrome?
(
- Contribution to journal › Article
- 2016
-
Mark
Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets
(
- Contribution to journal › Article
- 2014
-
Mark
Rare emergence of symptoms during long-term asymptomatic E. coli 83972 carriage, without altered virulence factor repertoire.
(
- Contribution to journal › Article
- 2011
-
Mark
Acute pyelonephritis and renal scarring are caused by dysfunctional innate immunity in mCxcr2 heterozygous mice.
(
- Contribution to journal › Article
-
Mark
Genetic control of the variable innate immune response to asymptomatic bacteriuria.
(
- Contribution to journal › Article
- 2010
-
Mark
HAMLET Treatment Delays Bladder Cancer Development.
(
- Contribution to journal › Article
- 2008
-
Mark
Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation?
(
- Contribution to journal › Article
-
Mark
Apoptosis and tumor cell death in response to HAMLET (human alpha-lactalbumin made lethal to tumor cells).
(
- Contribution to journal › Scientific review
-
Mark
TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections.
(
- Contribution to journal › Scientific review
-
Mark
Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection.
(
- Contribution to journal › Article